Preclinical Development of Human Monoclonal Antibodies for Postexposure Treatment of Crimean-Congo Hemorrhagic Fever

Project: Other project

StatusActive
Effective start/end date6/1/175/31/22

Funding

  • National Inst of Allergy & Infectious Di: $1,086,110.68